Εμφάνιση απλής εγγραφής

dc.creatorBourne R.R.A., Steinmetz J.D., Flaxman S., Briant P.S., Taylor H.R., Resnikoff S., Casson R.J., Abdoli A., Abu-Gharbieh E., Afshin A., Ahmadieh H., Akalu Y., Alamneh A.A., Alemayehu W., Alfaar A.S., Alipour V., Anbesu E.W., Androudi S., Arabloo J., Arditi A., Asaad M., Bagli E., Baig A.A., Bärnighausen T.W., Parodi M.B., Bhagavathula A.S., Bhardwaj N., Bhardwaj P., Bhattacharyya K., Bijani A., Bikbov M., Bottone M., Braithwaite T., Bron A.M., Butt Z.A., Cheng C.-Y., Chu D.-T., Cicinelli M.V., Coelho J.M., Dagnew B., Dai X., Dana R., Dandona L., Dandona R., Del Monte M.A., Deva J.P., Diaz D., Djalalinia S., Dreer L.E., Ehrlich J.R., Ellwein L.B., Emamian M.H., Fernandes A.G., Fischer F., Friedman D.S., Furtado J.M., Gaidhane A.M., Gaidhane S., Gazzard G., Gebremichael B., George R., Ghashghaee A., Golechha M., Hamidi S., Hammond B.R., Hartnett M.E.R., Hartono R.K., Hay S.I., Heidari G., Ho H.C., Hoang C.L., Househ M., Ibitoye S.E., Ilic I.M., Ilic M.D., Ingram A.D., Irvani S.S.N., Jha R.P., Kahloun R., Kandel H., Kasa A.S., Kempen J.H., Keramati M., Khairallah M., Khan E.A., Khanna R.C., Khatib M.N., Kim J.E., Kim Y.J., Kisa A., Kisa S., Koyanagi A., Kurmi O.P., Lansingh V.C., Leasher J.L., Leveziel N., Limburg H., Majdan M., Manafi N., Mansouri K., McAlinden C., Mohammadi S.F., Mohammadian-Hafshejani A., Mohammadpourhodki R., Mokdad A.H., Moosavi D., Morse A.R., Naderi M., Naidoo K.S., Nangia V., Nguyen C.T., Nguyen H.L.T., Ogundimu K., Olagunju A.T., Ostroff S.M., Panda-Jones S., Pesudovs K., Peto T., Syed Z.Q., Ur Rahman M.H., Ramulu P.Y., Rawaf D.L., Rawaf S., Reinig N., Robin A.L., Rossetti L., Safi S., Sahebkar A., Samy A.M., Saxena D., Serle J.B., Shaikh M.A., Shen T.T., Shibuya K., Shin J.I., Silva J.C., Silvester A., Singh J.A., Singhal D., Sitorus R.S., Skiadaresi E., Skirbekk V., Soheili A., Sousa R.A.R.C., Spurlock E.E., Stambolian D., Taddele B.W., Tadesse E.G., Tahhan N., Tareque Md.I., Topouzis F., Tran B.X., Travillian R.S., Tsilimbaris M.K., Varma R., Virgili G., Wang N., Wang Y.X., West S.K., Wong T.Y., Zaidi Z., Zewdie K.A., Jonas J.B., Vos T., GBD 2019 Blindness and Vision Impairment Collaborators, Vision Loss Expert Group of the Global Burden of Disease Studyen
dc.date.accessioned2023-01-31T07:39:56Z
dc.date.available2023-01-31T07:39:56Z
dc.date.issued2021
dc.identifier10.1016/S2214-109X(20)30425-3
dc.identifier.issn2214109X
dc.identifier.urihttp://hdl.handle.net/11615/72003
dc.description.abstractBackground: To contribute to the WHO initiative, VISION 2020: The Right to Sight, an assessment of global vision impairment in 2020 and temporal change is needed. We aimed to extensively update estimates of global vision loss burden, presenting estimates for 2020, temporal change over three decades between 1990–2020, and forecasts for 2050. Methods: We did a systematic review and meta-analysis of population-based surveys of eye disease from January, 1980, to October, 2018. Only studies with samples representative of the population and with clearly defined visual acuity testing protocols were included. We fitted hierarchical models to estimate 2020 prevalence (with 95% uncertainty intervals [UIs]) of mild vision impairment (presenting visual acuity ≥6/18 and <6/12), moderate and severe vision impairment (<6/18 to 3/60), and blindness (<3/60 or less than 10° visual field around central fixation); and vision impairment from uncorrected presbyopia (presenting near vision <N6 or <N8 at 40 cm where best-corrected distance visual acuity is ≥6/12). We forecast estimates of vision loss up to 2050. Findings: In 2020, an estimated 43·3 million (95% UI 37·6–48·4) people were blind, of whom 23·9 million (55%; 20·8–26·8) were estimated to be female. We estimated 295 million (267–325) people to have moderate and severe vision impairment, of whom 163 million (55%; 147–179) were female; 258 million (233–285) to have mild vision impairment, of whom 142 million (55%; 128–157) were female; and 510 million (371–667) to have visual impairment from uncorrected presbyopia, of whom 280 million (55%; 205–365) were female. Globally, between 1990 and 2020, among adults aged 50 years or older, age-standardised prevalence of blindness decreased by 28·5% (–29·4 to −27·7) and prevalence of mild vision impairment decreased slightly (–0·3%, −0·8 to −0·2), whereas prevalence of moderate and severe vision impairment increased slightly (2·5%, 1·9 to 3·2; insufficient data were available to calculate this statistic for vision impairment from uncorrected presbyopia). In this period, the number of people who were blind increased by 50·6% (47·8 to 53·4) and the number with moderate and severe vision impairment increased by 91·7% (87·6 to 95·8). By 2050, we predict 61·0 million (52·9 to 69·3) people will be blind, 474 million (428 to 518) will have moderate and severe vision impairment, 360 million (322 to 400) will have mild vision impairment, and 866 million (629 to 1150) will have uncorrected presbyopia. Interpretation: Age-adjusted prevalence of blindness has reduced over the past three decades, yet due to population growth, progress is not keeping pace with needs. We face enormous challenges in avoiding vision impairment as the global population grows and ages. Funding: Brien Holden Vision Institute, Fondation Thea, Fred Hollows Foundation, Bill & Melinda Gates Foundation, Lions Clubs International Foundation, Sightsavers International, and University of Heidelberg. © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 licenseen
dc.language.isoenen
dc.sourceThe Lancet Global Healthen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85098882179&doi=10.1016%2fS2214-109X%2820%2930425-3&partnerID=40&md5=4b4126df6eabcf756b7e006e0ed1070b
dc.subjectage related macular degenerationen
dc.subjectArticleen
dc.subjectbest corrected visual acuityen
dc.subjectblindnessen
dc.subjectcorrected distance visual acuityen
dc.subjectdisease burdenen
dc.subjectglobal disease burdenen
dc.subjecthealth care costen
dc.subjecthealth care deliveryen
dc.subjecthearing impairmenten
dc.subjecthumanen
dc.subjectlife expectancyen
dc.subjectlow back painen
dc.subjectmyopiaen
dc.subjectpopulation growthen
dc.subjectpresbyopiaen
dc.subjectprevalenceen
dc.subjectrefraction erroren
dc.subjectretina blood vesselen
dc.subjectsocial discriminationen
dc.subjectvisionen
dc.subjectvisual acuityen
dc.subjectvisual fielden
dc.subjectvisual impairmenten
dc.subjectageden
dc.subjectblindnessen
dc.subjectcataracten
dc.subjectcomplicationen
dc.subjecteye diseaseen
dc.subjectfemaleen
dc.subjectforecastingen
dc.subjectglaucomaen
dc.subjectglobal disease burdenen
dc.subjectglobal healthen
dc.subjectlow visionen
dc.subjectmacular degenerationen
dc.subjectmaleen
dc.subjectmeta analysisen
dc.subjectmiddle ageden
dc.subjectvery elderlyen
dc.subjectvisual acuityen
dc.subjectAgeden
dc.subjectAged, 80 and overen
dc.subjectBlindnessen
dc.subjectCataracten
dc.subjectEye Diseasesen
dc.subjectFemaleen
dc.subjectForecastingen
dc.subjectGlaucomaen
dc.subjectGlobal Burden of Diseaseen
dc.subjectGlobal Healthen
dc.subjectHumansen
dc.subjectMacular Degenerationen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectPresbyopiaen
dc.subjectVision, Lowen
dc.subjectVisual Acuityen
dc.subjectElsevier Ltden
dc.titleTrends in prevalence of blindness and distance and near vision impairment over 30 years: An analysis for the Global Burden of Disease Studyen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής